COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,170 Articles (22,703 medRxiv, 8,467 bioRxiv)

Most recent first Previous |  Page 161: Articles 1601-1610  | Next

The Main protease (Mpro) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII
Pagotto, A., Uliana, F., Nordio, G., Pietrangelini, A., Acquasaliente, L., Macchia, M. L., Bellanda, M., Gatto, B., De Silvestro, G., Marson, P., Simioni, P., Picotti, P., De Filippis, V.
10.1101/2024.09.05.611400 — Posted: 2024-09-05
Nsp1 stalls DNA Polymerase alpha at DNA hairpins
Baranovskiy, A. G., Morstadt, L. M., Babayeva, N. D., Tahirov, T. H.
10.1101/2024.09.03.608162 — Posted: 2024-09-05
Genomic Epidemiology of SARS-CoV-2 in Norfolk, UK, March 2020 - December 2022
Hayles, E. H., Page, A. J., Guitian, J., Kingsley, R. A., The COVID-19 Genomics UK Consortium, , Langridge, G. C.
10.1101/2024.09.05.611382 — Posted: 2024-09-05
Oxidative stress and PARP activation in the lungs is an early event in COVID-19 pneumonia
Juhasz, P., Bohus, P., Sipos, A., Curtin, N., Mehes, G., Bai, P.
10.1101/2024.09.03.24312996 — Posted: 2024-09-04
The Impact of COVID-19 Lockdowns on Mental Health: A Comparative Study
Orgad, K.
10.1101/2024.09.02.24312962 — Posted: 2024-09-04
Protective Effects of Psychiatric Medications against COVID-19 Mortality Before Vaccines
Machado-Vieira, R., Krause, T. M., Jones, G., Teixeira, A. L., Shahani, L. R., Lane, S. D., Soares, J. C., Truong, C.
10.1101/2024.09.02.24312967 — Posted: 2024-09-04
Exploring COVID-19 Pandemic Perceptions and Vaccine Uptake among Community Members and Primary Healthcare Workers in Nigeria: A Mixed Methods Study.
Bakare, A. A., Sogbesan, A., Herzig Van Wees, S. A., Salako, J. A., Bakare, D., Olojede, O. E., Akinsola, K., Bakare, O. R., Falade, A. G., King, C.
10.1101/2024.09.02.24312966 — Posted: 2024-09-04
Short-term and Long-Term Healthcare Costs Attributable to diagnosed COVID-19 in Ontario; Canada: A Population-Based Matched Cohort Study
Sander, B., Mishra, S., Swayze, S., Sahakyan, Y., Duchen, R., Quinn, K. L., Janjua, N. Z., Sbihi, H., Kwong, J. C.
10.1101/2024.09.04.24313064 — Posted: 2024-09-04
Structural and molecular basis of the epistasis effect in enhanced affinity between SARS-CoV-2 KP.3 and ACE2
Feng, L., Sun, Z., Zhang, Y., Jian, F., Yang, S., Yu, L., Wang, J., Shao, F., Wang, X., Cao, Y.
10.1101/2024.09.03.610799 — Posted: 2024-09-04
Optimisation of a multiplexed, high throughput assay to measure neutralising antibodies against SARS-CoV-2 variants.
Ashley, C. L., Bloul, M., Alca, S., Smith, L., Jin, W., Khoury, D., Counoupas, C., Davenport, M. P., Triccas, J. A., Steain, M.
10.1101/2024.09.01.610733 — Posted: 2024-09-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).